Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI) developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine a widely-used NRTI meaning that the two compounds are mirror images of each other.
This page contains content from the copyrighted Wikipedia article "Racivir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
